nos2 Search Results


94
Miltenyi Biotec inos antibody
Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the <t>iNOS</t> stained with the <t>iNOS</t> <t>antibody</t> conjugated with FITC.
Inos Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inos antibody/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
inos antibody - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

99
Thermo Fisher gene exp nos2 hs01075529 m1
Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the <t>iNOS</t> stained with the <t>iNOS</t> <t>antibody</t> conjugated with FITC.
Gene Exp Nos2 Hs01075529 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp nos2 hs01075529 m1/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
gene exp nos2 hs01075529 m1 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology arg1
HIIT reduced PNN accumulation and promoted microglial M2 polarization in the mPFC. (A and B) Triple immunofluorescence staining in the mPFC showing PNN, Iba1, and iNOS ( A ) or PNN, Iba1, and <t>Arg1</t> ( B ). OA rats showed increased PNN expression and pro-inflammatory (Iba1 + iNOS⁺) microglia, while HIIT reduced PNN levels and promoted anti-inflammatory (Iba1 + Arg1⁺) phenotypes. (C and D) Protein expression of iNOS, Arg1, IL-10, IL-1β, and TNF-α in the mPFC, detected by western blot ( C ) and quantified by bar graphs ( D ) ( n = 6). Statistical methods used: One-way ANOVA. ** p < 0.01 vs. the sham group, ## p < 0.01 vs. the OA group. Data are represented as mean ± SD.
Arg1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/arg1/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
arg1 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

96
Proteintech antibodies against inos
HIIT reduced PNN accumulation and promoted microglial M2 polarization in the mPFC. (A and B) Triple immunofluorescence staining in the mPFC showing PNN, Iba1, and iNOS ( A ) or PNN, Iba1, and <t>Arg1</t> ( B ). OA rats showed increased PNN expression and pro-inflammatory (Iba1 + iNOS⁺) microglia, while HIIT reduced PNN levels and promoted anti-inflammatory (Iba1 + Arg1⁺) phenotypes. (C and D) Protein expression of iNOS, Arg1, IL-10, IL-1β, and TNF-α in the mPFC, detected by western blot ( C ) and quantified by bar graphs ( D ) ( n = 6). Statistical methods used: One-way ANOVA. ** p < 0.01 vs. the sham group, ## p < 0.01 vs. the OA group. Data are represented as mean ± SD.
Antibodies Against Inos, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against inos/product/Proteintech
Average 96 stars, based on 1 article reviews
antibodies against inos - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

96
Proteintech inos
HIIT reduced PNN accumulation and promoted microglial M2 polarization in the mPFC. (A and B) Triple immunofluorescence staining in the mPFC showing PNN, Iba1, and iNOS ( A ) or PNN, Iba1, and <t>Arg1</t> ( B ). OA rats showed increased PNN expression and pro-inflammatory (Iba1 + iNOS⁺) microglia, while HIIT reduced PNN levels and promoted anti-inflammatory (Iba1 + Arg1⁺) phenotypes. (C and D) Protein expression of iNOS, Arg1, IL-10, IL-1β, and TNF-α in the mPFC, detected by western blot ( C ) and quantified by bar graphs ( D ) ( n = 6). Statistical methods used: One-way ANOVA. ** p < 0.01 vs. the sham group, ## p < 0.01 vs. the OA group. Data are represented as mean ± SD.
Inos, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inos/product/Proteintech
Average 96 stars, based on 1 article reviews
inos - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

93
Elabscience Biotechnology protein assay kit
HIIT reduced PNN accumulation and promoted microglial M2 polarization in the mPFC. (A and B) Triple immunofluorescence staining in the mPFC showing PNN, Iba1, and iNOS ( A ) or PNN, Iba1, and <t>Arg1</t> ( B ). OA rats showed increased PNN expression and pro-inflammatory (Iba1 + iNOS⁺) microglia, while HIIT reduced PNN levels and promoted anti-inflammatory (Iba1 + Arg1⁺) phenotypes. (C and D) Protein expression of iNOS, Arg1, IL-10, IL-1β, and TNF-α in the mPFC, detected by western blot ( C ) and quantified by bar graphs ( D ) ( n = 6). Statistical methods used: One-way ANOVA. ** p < 0.01 vs. the sham group, ## p < 0.01 vs. the OA group. Data are represented as mean ± SD.
Protein Assay Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein assay kit/product/Elabscience Biotechnology
Average 93 stars, based on 1 article reviews
protein assay kit - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

94
Elabscience Biotechnology mouse inos
HIIT reduced PNN accumulation and promoted microglial M2 polarization in the mPFC. (A and B) Triple immunofluorescence staining in the mPFC showing PNN, Iba1, and iNOS ( A ) or PNN, Iba1, and <t>Arg1</t> ( B ). OA rats showed increased PNN expression and pro-inflammatory (Iba1 + iNOS⁺) microglia, while HIIT reduced PNN levels and promoted anti-inflammatory (Iba1 + Arg1⁺) phenotypes. (C and D) Protein expression of iNOS, Arg1, IL-10, IL-1β, and TNF-α in the mPFC, detected by western blot ( C ) and quantified by bar graphs ( D ) ( n = 6). Statistical methods used: One-way ANOVA. ** p < 0.01 vs. the sham group, ## p < 0.01 vs. the OA group. Data are represented as mean ± SD.
Mouse Inos, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse inos/product/Elabscience Biotechnology
Average 94 stars, based on 1 article reviews
mouse inos - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology inos
A. Neutrophils were treated with increasing concentrations of zymosan for indicated time periods, and were subjected to Western blot analysis. B. Neutrophils were incubated with zymosan for 15 min, post-treated with 0.7% isoflurane for 15 min, followed by a continuous incubation with zymosan for a total of 8 h before Western blot analysis. β-actin was used as an inner control for whole cell lysates. C. Neutrophils were co-transfected with or without an <t>iNOS-luc</t> reporter plasmid and indicated siRNAs. The promoter activity of iNOS was determined in the cell lysates after zymosan treatment for 6 h. D. , E. Neutrophils were pretreated with NAI (D) or transfected with <t>NF-κB</t> <t>p65</t> siRNA (E), followed by incubation with zymosan for 8 h. The nuclear or whole cell lysates were prepared for Western blot analysis. Lamin B was used as an inner control for the lysates of the nuclear fraction. F. Neutrophils were treated as described in (D), followed by incubation with zymosan for 6 h prior to RT-PCR analysis. G. Neutrophils were treated as described in (D), followed by measurement of NO and ONOO − production. H. Neutrophils were treated as described in (B), and the nuclear lysates were prepared for Western blot analysis. Data are represented as the mean ± SEM of 3 replicates or representative of 3 independent experiments. * P < 0.05, # P < 0.01, as compared with the cells exposed to vehicle alone (A). * P < 0.05, # P < 0.01, as compared with the cells exposed to zymosan alone (B-H), or zymosan + scrambled siRNA (E).
Inos, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inos/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
inos - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Elabscience Biotechnology inducible nitric oxide synthetase inos
A. Neutrophils were treated with increasing concentrations of zymosan for indicated time periods, and were subjected to Western blot analysis. B. Neutrophils were incubated with zymosan for 15 min, post-treated with 0.7% isoflurane for 15 min, followed by a continuous incubation with zymosan for a total of 8 h before Western blot analysis. β-actin was used as an inner control for whole cell lysates. C. Neutrophils were co-transfected with or without an <t>iNOS-luc</t> reporter plasmid and indicated siRNAs. The promoter activity of iNOS was determined in the cell lysates after zymosan treatment for 6 h. D. , E. Neutrophils were pretreated with NAI (D) or transfected with <t>NF-κB</t> <t>p65</t> siRNA (E), followed by incubation with zymosan for 8 h. The nuclear or whole cell lysates were prepared for Western blot analysis. Lamin B was used as an inner control for the lysates of the nuclear fraction. F. Neutrophils were treated as described in (D), followed by incubation with zymosan for 6 h prior to RT-PCR analysis. G. Neutrophils were treated as described in (D), followed by measurement of NO and ONOO − production. H. Neutrophils were treated as described in (B), and the nuclear lysates were prepared for Western blot analysis. Data are represented as the mean ± SEM of 3 replicates or representative of 3 independent experiments. * P < 0.05, # P < 0.01, as compared with the cells exposed to vehicle alone (A). * P < 0.05, # P < 0.01, as compared with the cells exposed to zymosan alone (B-H), or zymosan + scrambled siRNA (E).
Inducible Nitric Oxide Synthetase Inos, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inducible nitric oxide synthetase inos/product/Elabscience Biotechnology
Average 93 stars, based on 1 article reviews
inducible nitric oxide synthetase inos - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

85
Taconic Biosciences inos knockout mice
A. Neutrophils were treated with increasing concentrations of zymosan for indicated time periods, and were subjected to Western blot analysis. B. Neutrophils were incubated with zymosan for 15 min, post-treated with 0.7% isoflurane for 15 min, followed by a continuous incubation with zymosan for a total of 8 h before Western blot analysis. β-actin was used as an inner control for whole cell lysates. C. Neutrophils were co-transfected with or without an <t>iNOS-luc</t> reporter plasmid and indicated siRNAs. The promoter activity of iNOS was determined in the cell lysates after zymosan treatment for 6 h. D. , E. Neutrophils were pretreated with NAI (D) or transfected with <t>NF-κB</t> <t>p65</t> siRNA (E), followed by incubation with zymosan for 8 h. The nuclear or whole cell lysates were prepared for Western blot analysis. Lamin B was used as an inner control for the lysates of the nuclear fraction. F. Neutrophils were treated as described in (D), followed by incubation with zymosan for 6 h prior to RT-PCR analysis. G. Neutrophils were treated as described in (D), followed by measurement of NO and ONOO − production. H. Neutrophils were treated as described in (B), and the nuclear lysates were prepared for Western blot analysis. Data are represented as the mean ± SEM of 3 replicates or representative of 3 independent experiments. * P < 0.05, # P < 0.01, as compared with the cells exposed to vehicle alone (A). * P < 0.05, # P < 0.01, as compared with the cells exposed to zymosan alone (B-H), or zymosan + scrambled siRNA (E).
Inos Knockout Mice, supplied by Taconic Biosciences, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inos knockout mice/product/Taconic Biosciences
Average 85 stars, based on 1 article reviews
inos knockout mice - by Bioz Stars, 2026-05
85/100 stars
  Buy from Supplier

85
Rockland Immunochemicals inos
A. Neutrophils were treated with increasing concentrations of zymosan for indicated time periods, and were subjected to Western blot analysis. B. Neutrophils were incubated with zymosan for 15 min, post-treated with 0.7% isoflurane for 15 min, followed by a continuous incubation with zymosan for a total of 8 h before Western blot analysis. β-actin was used as an inner control for whole cell lysates. C. Neutrophils were co-transfected with or without an <t>iNOS-luc</t> reporter plasmid and indicated siRNAs. The promoter activity of iNOS was determined in the cell lysates after zymosan treatment for 6 h. D. , E. Neutrophils were pretreated with NAI (D) or transfected with <t>NF-κB</t> <t>p65</t> siRNA (E), followed by incubation with zymosan for 8 h. The nuclear or whole cell lysates were prepared for Western blot analysis. Lamin B was used as an inner control for the lysates of the nuclear fraction. F. Neutrophils were treated as described in (D), followed by incubation with zymosan for 6 h prior to RT-PCR analysis. G. Neutrophils were treated as described in (D), followed by measurement of NO and ONOO − production. H. Neutrophils were treated as described in (B), and the nuclear lysates were prepared for Western blot analysis. Data are represented as the mean ± SEM of 3 replicates or representative of 3 independent experiments. * P < 0.05, # P < 0.01, as compared with the cells exposed to vehicle alone (A). * P < 0.05, # P < 0.01, as compared with the cells exposed to zymosan alone (B-H), or zymosan + scrambled siRNA (E).
Inos, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inos/product/Rockland Immunochemicals
Average 85 stars, based on 1 article reviews
inos - by Bioz Stars, 2026-05
85/100 stars
  Buy from Supplier

91
Boster Bio rabbit anti nanos2
A. Neutrophils were treated with increasing concentrations of zymosan for indicated time periods, and were subjected to Western blot analysis. B. Neutrophils were incubated with zymosan for 15 min, post-treated with 0.7% isoflurane for 15 min, followed by a continuous incubation with zymosan for a total of 8 h before Western blot analysis. β-actin was used as an inner control for whole cell lysates. C. Neutrophils were co-transfected with or without an <t>iNOS-luc</t> reporter plasmid and indicated siRNAs. The promoter activity of iNOS was determined in the cell lysates after zymosan treatment for 6 h. D. , E. Neutrophils were pretreated with NAI (D) or transfected with <t>NF-κB</t> <t>p65</t> siRNA (E), followed by incubation with zymosan for 8 h. The nuclear or whole cell lysates were prepared for Western blot analysis. Lamin B was used as an inner control for the lysates of the nuclear fraction. F. Neutrophils were treated as described in (D), followed by incubation with zymosan for 6 h prior to RT-PCR analysis. G. Neutrophils were treated as described in (D), followed by measurement of NO and ONOO − production. H. Neutrophils were treated as described in (B), and the nuclear lysates were prepared for Western blot analysis. Data are represented as the mean ± SEM of 3 replicates or representative of 3 independent experiments. * P < 0.05, # P < 0.01, as compared with the cells exposed to vehicle alone (A). * P < 0.05, # P < 0.01, as compared with the cells exposed to zymosan alone (B-H), or zymosan + scrambled siRNA (E).
Rabbit Anti Nanos2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti nanos2/product/Boster Bio
Average 91 stars, based on 1 article reviews
rabbit anti nanos2 - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

Image Search Results


Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the iNOS stained with the iNOS antibody conjugated with FITC.

Journal: Materials today. Bio

Article Title: Precise delivery of doxorubicin and imiquimod through pH-responsive tumor microenvironment-active targeting micelles for chemo- and immunotherapy.

doi: 10.1016/j.mtbio.2022.100482

Figure Lengend Snippet: Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the iNOS stained with the iNOS antibody conjugated with FITC.

Article Snippet: After 30 min, the tissue slice was stained with diluted iNOS antibody (Miltenyi Biotec, catalog: 130-116-357) at 4 C overnight.

Techniques: Immunostaining, Immunohistochemistry, Staining

HIIT reduced PNN accumulation and promoted microglial M2 polarization in the mPFC. (A and B) Triple immunofluorescence staining in the mPFC showing PNN, Iba1, and iNOS ( A ) or PNN, Iba1, and Arg1 ( B ). OA rats showed increased PNN expression and pro-inflammatory (Iba1 + iNOS⁺) microglia, while HIIT reduced PNN levels and promoted anti-inflammatory (Iba1 + Arg1⁺) phenotypes. (C and D) Protein expression of iNOS, Arg1, IL-10, IL-1β, and TNF-α in the mPFC, detected by western blot ( C ) and quantified by bar graphs ( D ) ( n = 6). Statistical methods used: One-way ANOVA. ** p < 0.01 vs. the sham group, ## p < 0.01 vs. the OA group. Data are represented as mean ± SD.

Journal: Scientific Reports

Article Title: High-intensity interval training remodels perineuronal nets in the medial prefrontal cortex to drive microglial polarization and alleviate osteoarthritis pain

doi: 10.1038/s41598-026-40823-w

Figure Lengend Snippet: HIIT reduced PNN accumulation and promoted microglial M2 polarization in the mPFC. (A and B) Triple immunofluorescence staining in the mPFC showing PNN, Iba1, and iNOS ( A ) or PNN, Iba1, and Arg1 ( B ). OA rats showed increased PNN expression and pro-inflammatory (Iba1 + iNOS⁺) microglia, while HIIT reduced PNN levels and promoted anti-inflammatory (Iba1 + Arg1⁺) phenotypes. (C and D) Protein expression of iNOS, Arg1, IL-10, IL-1β, and TNF-α in the mPFC, detected by western blot ( C ) and quantified by bar graphs ( D ) ( n = 6). Statistical methods used: One-way ANOVA. ** p < 0.01 vs. the sham group, ## p < 0.01 vs. the OA group. Data are represented as mean ± SD.

Article Snippet: Equal amounts of protein (30–50 μg) were separated on 10–12% SDS-PAGE gels (FuturePAGE, ACE Biotechnology, ET15420LGel), transferred to PVDF membranes (Millipore, Billerica, MA, USA, IPVH00010), blocked with 5% skim milk (BD Biosciences, Franklin Lakes, NJ, USA) for 1 h, and incubated overnight at 4 °C with primary antibodies against β-actin (1:5000, Servicebio, GB15003-100), COL2A1 (1:1000, Santa Cruz Biotechnology, sc-52658), MMP13 (1:1000, Proteintech, 18165-1-AP), iNOS (1:1000, Santa Cruz Biotechnology, sc-7271), Arg1 (1:1000, Santa Cruz Biotechnology, sc-47715), IL-10 (1:1000, Santa Cruz Biotechnology, sc-32815), IL-1β (1:1000, Santa Cruz Biotechnology, sc-12742), and TNF-α (1:1000, Santa Cruz Biotechnology, sc-52746).

Techniques: Immunofluorescence, Staining, Expressing, Western Blot

PNNs degradation and HIIT alleviate neuroinflammation in the mPFC of OA rats. ( A - D ) Representative triple immunofluorescence staining images of the mPFC, showing the distribution patterns of PNNs, Iba1 (microglial marker), and iNOS ( A ) or Arg1 ( C ). Quantification of panel A is shown in ( B ), and quantification of panel C is shown in ( D ) ( n = 6). ( E and F ) Western blot analysis and corresponding quantification of inflammatory markers, including iNOS, Arg1, IL-1β, TNF-α, and IL-10 in mPFC tissue lysates ( n = 6). Statistical methods used: One-way ANOVA. ** p < 0.01 vs. the OA+Vehicle group, ns not significant vs. the OA+ChABC group.Data are presented as mean ± SD.

Journal: Scientific Reports

Article Title: High-intensity interval training remodels perineuronal nets in the medial prefrontal cortex to drive microglial polarization and alleviate osteoarthritis pain

doi: 10.1038/s41598-026-40823-w

Figure Lengend Snippet: PNNs degradation and HIIT alleviate neuroinflammation in the mPFC of OA rats. ( A - D ) Representative triple immunofluorescence staining images of the mPFC, showing the distribution patterns of PNNs, Iba1 (microglial marker), and iNOS ( A ) or Arg1 ( C ). Quantification of panel A is shown in ( B ), and quantification of panel C is shown in ( D ) ( n = 6). ( E and F ) Western blot analysis and corresponding quantification of inflammatory markers, including iNOS, Arg1, IL-1β, TNF-α, and IL-10 in mPFC tissue lysates ( n = 6). Statistical methods used: One-way ANOVA. ** p < 0.01 vs. the OA+Vehicle group, ns not significant vs. the OA+ChABC group.Data are presented as mean ± SD.

Article Snippet: Equal amounts of protein (30–50 μg) were separated on 10–12% SDS-PAGE gels (FuturePAGE, ACE Biotechnology, ET15420LGel), transferred to PVDF membranes (Millipore, Billerica, MA, USA, IPVH00010), blocked with 5% skim milk (BD Biosciences, Franklin Lakes, NJ, USA) for 1 h, and incubated overnight at 4 °C with primary antibodies against β-actin (1:5000, Servicebio, GB15003-100), COL2A1 (1:1000, Santa Cruz Biotechnology, sc-52658), MMP13 (1:1000, Proteintech, 18165-1-AP), iNOS (1:1000, Santa Cruz Biotechnology, sc-7271), Arg1 (1:1000, Santa Cruz Biotechnology, sc-47715), IL-10 (1:1000, Santa Cruz Biotechnology, sc-32815), IL-1β (1:1000, Santa Cruz Biotechnology, sc-12742), and TNF-α (1:1000, Santa Cruz Biotechnology, sc-52746).

Techniques: Immunofluorescence, Staining, Marker, Western Blot

PNN remodeling precedes microglial polarization. ( A - D ) Representative triple immunofluorescence staining images of the mPFC, showing PNN, Iba1, and iNOS ( A ), or PNN, Iba1, and Arg1 ( C ). Quantification of panel A is shown in ( B ), and quantification of panel C is shown in ( D ) ( n = 6). Statistical methods used: One-way ANOVA. ** p < 0.01. Data are presented as mean ± SD.

Journal: Scientific Reports

Article Title: High-intensity interval training remodels perineuronal nets in the medial prefrontal cortex to drive microglial polarization and alleviate osteoarthritis pain

doi: 10.1038/s41598-026-40823-w

Figure Lengend Snippet: PNN remodeling precedes microglial polarization. ( A - D ) Representative triple immunofluorescence staining images of the mPFC, showing PNN, Iba1, and iNOS ( A ), or PNN, Iba1, and Arg1 ( C ). Quantification of panel A is shown in ( B ), and quantification of panel C is shown in ( D ) ( n = 6). Statistical methods used: One-way ANOVA. ** p < 0.01. Data are presented as mean ± SD.

Article Snippet: Equal amounts of protein (30–50 μg) were separated on 10–12% SDS-PAGE gels (FuturePAGE, ACE Biotechnology, ET15420LGel), transferred to PVDF membranes (Millipore, Billerica, MA, USA, IPVH00010), blocked with 5% skim milk (BD Biosciences, Franklin Lakes, NJ, USA) for 1 h, and incubated overnight at 4 °C with primary antibodies against β-actin (1:5000, Servicebio, GB15003-100), COL2A1 (1:1000, Santa Cruz Biotechnology, sc-52658), MMP13 (1:1000, Proteintech, 18165-1-AP), iNOS (1:1000, Santa Cruz Biotechnology, sc-7271), Arg1 (1:1000, Santa Cruz Biotechnology, sc-47715), IL-10 (1:1000, Santa Cruz Biotechnology, sc-32815), IL-1β (1:1000, Santa Cruz Biotechnology, sc-12742), and TNF-α (1:1000, Santa Cruz Biotechnology, sc-52746).

Techniques: Immunofluorescence, Staining

A. Neutrophils were treated with increasing concentrations of zymosan for indicated time periods, and were subjected to Western blot analysis. B. Neutrophils were incubated with zymosan for 15 min, post-treated with 0.7% isoflurane for 15 min, followed by a continuous incubation with zymosan for a total of 8 h before Western blot analysis. β-actin was used as an inner control for whole cell lysates. C. Neutrophils were co-transfected with or without an iNOS-luc reporter plasmid and indicated siRNAs. The promoter activity of iNOS was determined in the cell lysates after zymosan treatment for 6 h. D. , E. Neutrophils were pretreated with NAI (D) or transfected with NF-κB p65 siRNA (E), followed by incubation with zymosan for 8 h. The nuclear or whole cell lysates were prepared for Western blot analysis. Lamin B was used as an inner control for the lysates of the nuclear fraction. F. Neutrophils were treated as described in (D), followed by incubation with zymosan for 6 h prior to RT-PCR analysis. G. Neutrophils were treated as described in (D), followed by measurement of NO and ONOO − production. H. Neutrophils were treated as described in (B), and the nuclear lysates were prepared for Western blot analysis. Data are represented as the mean ± SEM of 3 replicates or representative of 3 independent experiments. * P < 0.05, # P < 0.01, as compared with the cells exposed to vehicle alone (A). * P < 0.05, # P < 0.01, as compared with the cells exposed to zymosan alone (B-H), or zymosan + scrambled siRNA (E).

Journal: Oncotarget

Article Title: Subanesthetic isoflurane relieves zymosan-induced neutrophil inflammatory response by targeting NMDA glutamate receptor and Toll-like receptor 2 signaling

doi: 10.18632/oncotarget.9091

Figure Lengend Snippet: A. Neutrophils were treated with increasing concentrations of zymosan for indicated time periods, and were subjected to Western blot analysis. B. Neutrophils were incubated with zymosan for 15 min, post-treated with 0.7% isoflurane for 15 min, followed by a continuous incubation with zymosan for a total of 8 h before Western blot analysis. β-actin was used as an inner control for whole cell lysates. C. Neutrophils were co-transfected with or without an iNOS-luc reporter plasmid and indicated siRNAs. The promoter activity of iNOS was determined in the cell lysates after zymosan treatment for 6 h. D. , E. Neutrophils were pretreated with NAI (D) or transfected with NF-κB p65 siRNA (E), followed by incubation with zymosan for 8 h. The nuclear or whole cell lysates were prepared for Western blot analysis. Lamin B was used as an inner control for the lysates of the nuclear fraction. F. Neutrophils were treated as described in (D), followed by incubation with zymosan for 6 h prior to RT-PCR analysis. G. Neutrophils were treated as described in (D), followed by measurement of NO and ONOO − production. H. Neutrophils were treated as described in (B), and the nuclear lysates were prepared for Western blot analysis. Data are represented as the mean ± SEM of 3 replicates or representative of 3 independent experiments. * P < 0.05, # P < 0.01, as compared with the cells exposed to vehicle alone (A). * P < 0.05, # P < 0.01, as compared with the cells exposed to zymosan alone (B-H), or zymosan + scrambled siRNA (E).

Article Snippet: The small interfering RNA (siRNA) duplexes corresponding to mouse TLR2 (sc-40257), TLR4 (sc-40261), MyD88 (sc-35987), c-Src (sc-29859), p47 phox (sc-151963), p38 MAPK (sc-29434), NF-κB p65 (sc-29411), iNOS (sc-36092), NMDA receptor subunit NR1 (sc-36082), and scrambled siRNA (sc-44230) were purchased from Santa Cruz Biotechnology, Inc. (Dallas, Texas, USA).

Techniques: Western Blot, Incubation, Control, Transfection, Plasmid Preparation, Activity Assay, Reverse Transcription Polymerase Chain Reaction

Zymosan induces ROS production through a TLR2/MyD88/c-Src/NADPH oxidase pathway, which in turn caused the activation of p38 MAPK and consequently the activation and nuclear translocation of NF-κB. NF-κB thus switches on iNOS expression, and increases NO production and ONOO − release from neutrophils, which eventually permeabilizes adjacent PMVECs. Subanesthetic isoflurane exerts a protective role for this pathological process by inhibiting c-Src activity, which is probably attributed to isoflurane targeting of the NMDA glutamate receptor and thereby suppression of the calcium signaling in neutrophils.

Journal: Oncotarget

Article Title: Subanesthetic isoflurane relieves zymosan-induced neutrophil inflammatory response by targeting NMDA glutamate receptor and Toll-like receptor 2 signaling

doi: 10.18632/oncotarget.9091

Figure Lengend Snippet: Zymosan induces ROS production through a TLR2/MyD88/c-Src/NADPH oxidase pathway, which in turn caused the activation of p38 MAPK and consequently the activation and nuclear translocation of NF-κB. NF-κB thus switches on iNOS expression, and increases NO production and ONOO − release from neutrophils, which eventually permeabilizes adjacent PMVECs. Subanesthetic isoflurane exerts a protective role for this pathological process by inhibiting c-Src activity, which is probably attributed to isoflurane targeting of the NMDA glutamate receptor and thereby suppression of the calcium signaling in neutrophils.

Article Snippet: The small interfering RNA (siRNA) duplexes corresponding to mouse TLR2 (sc-40257), TLR4 (sc-40261), MyD88 (sc-35987), c-Src (sc-29859), p47 phox (sc-151963), p38 MAPK (sc-29434), NF-κB p65 (sc-29411), iNOS (sc-36092), NMDA receptor subunit NR1 (sc-36082), and scrambled siRNA (sc-44230) were purchased from Santa Cruz Biotechnology, Inc. (Dallas, Texas, USA).

Techniques: Activation Assay, Translocation Assay, Expressing, Activity Assay